부산대학교 도서관

Treon, SP; Branagan, AR; Ioakimidis, L; Soumerai, JD; Patterson, CJ; Turnbull, B; Wasi, P; Emmanouilides, C; Frankel, SR; Lister, A

BLOOD. 113(16):3673-3678

Treon SP; Ioakimidis L; Soumerai JD; Patterson CJ; Sheehy P; Nelson M; Willen M; Matous J; Mattern J 2nd; Diener JG; Keogh GP; Myers TJ; Boral A; Birner A; Esseltine DL; Ghobrial IM; Treon, Steven P; Ioakimidis, Leukothea; Soumerai, Jacob D; Patterson, Christopher J

Journal of Clinical Oncology. 8/10/2009, Vol. 27 Issue 23, p3830-3835. 6p.

Ioakimidis L; Patterson CJ; Hunter ZR; Soumerai JD; Manning RJ; Turnbull B; Sheehy P; Treon SP

Clinical Lymphoma & Myeloma; 2009 Mar, Vol. 9 Issue 1, p62-66, 5p

Simon SR; Trinacty CM; Soumerai SB; Piette JD; Meigs JB; Shi P; Ensroth A; Ross-Degnan D; Simon, Steven R; Trinacty, Connie Mah; Soumerai, Stephen B; Piette, John D; Meigs, James B; Shi, Ping; Ensroth, Arthur; Ross-Degnan, Dennis

Diabetes Care; Jul2010, Vol. 33 Issue 7, p1452-1453, 2p

Treon SP; Hatjiharissi E; Leleu X; Moreau AS; Roccaro A; Hunter ZR; Soumerai JD; Ciccarelli B; Xu L; Sacco A; Ngo HT; Jia X; Yang C; Adamia S; Branagan AR; Ho AW; Santos DD; Tournilhac O; Manning RJ; Leduc R; et al

Clinical Lymphoma & Myeloma (CLIN LYMPHOMA MYELOMA), Aug2007 Supplement 5; 7: S199-206. (1p)

Trinacty CM; Adams AS; Soumerai SB; Zhang F; Meigs JB; Piette JD; Ross-Degnan D; Trinacty, Connie M; Adams, Alyce S; Soumerai, Stephen B; Zhang, Fang; Meigs, James B; Piette, John D; Ross-Degnan, Dennis

BMC Health Services Research (BMC HEALTH SERV RES), 2009; 9: 24-24. (1p)

Cho C; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Redd R; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Haydu JE; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Johnson PC; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Barnes JA; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Takvorian R; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Hochberg EP; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Ford J; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Abramson JS; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Soumerai JD; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE; In Process

Haydu JE; Department of Lymphoma, Mass General Cancer Center, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Redd RA; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA.; Lei MM; Department of Lymphoma, Mass General Cancer Center, Boston, MA.; Hochberg EP; Department of Lymphoma, Mass General Cancer Center, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Barnes JA; Department of Lymphoma, Mass General Cancer Center, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Armand P; Department of Medicine, Harvard Medical School, Boston, MA.; Department of Lymphoma, Dana-Farber Brigham Cancer Center, Boston, MA.; Soumerai JD; Department of Lymphoma, Mass General Cancer Center, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Eichler AF; Department of Lymphoma, Mass General Cancer Center, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Jacobsen ED; Department of Medicine, Harvard Medical School, Boston, MA.; Department of Lymphoma, Dana-Farber Brigham Cancer Center, Boston, MA.; Jordan JT; Department of Lymphoma, Mass General Cancer Center, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Jacobson CA; Department of Medicine, Harvard Medical School, Boston, MA.; Department of Lymphoma, Dana-Farber Brigham Cancer Center, Boston, MA.; LaCasce AS; Department of Medicine, Harvard Medical School, Boston, MA.; Department of Lymphoma, Dana-Farber Brigham Cancer Center, Boston, MA.; Arrillaga-Romany I; Department of Lymphoma, Mass General Cancer Center, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; McFaline-Figueroa JR; Department of Neurology and Medicine, New York University, New York, NY.; Plotkin SR; Department of Lymphoma, Mass General Cancer Center, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Takvorian RW; Department of Lymphoma, Mass General Cancer Center, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Chukwueke UN; Department of Medicine, Harvard Medical School, Boston, MA.; Department of Lymphoma, Dana-Farber Brigham Cancer Center, Boston, MA.; Crombie JL; Department of Medicine, Harvard Medical School, Boston, MA.; Department of Lymphoma, Dana-Farber Brigham Cancer Center, Boston, MA.; Johnson PC; Department of Lymphoma, Mass General Cancer Center, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Karschnia P; Department of Lymphoma, Mass General Cancer Center, Boston, MA.; Department of Neurosurgery, Universitätsklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.; Dietrich J; Department of Lymphoma, Mass General Cancer Center, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Nayak L; Department of Medicine, Harvard Medical School, Boston, MA.; Department of Lymphoma, Dana-Farber Brigham Cancer Center, Boston, MA.; Abramson JS; Department of Lymphoma, Mass General Cancer Center, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.

Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Kaulen LD; Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. leon.kaulen@med.uni-heidelberg.de.; Department of Neurology and European center for Neurooncology (EZN), University Hospital Heidelberg, Heidelberg University, Heidelberg, Germany. leon.kaulen@med.uni-heidelberg.de.; Clinical Cooperation Unit Neuro-Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany. leon.kaulen@med.uni-heidelberg.de.; Karschnia P; Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Department of Neurosurgery, Universitaetsklinikum Erlangen, Friedrich-Alexander- University, Erlangen, Germany.; Doubrovinskaia S; Department of Neurology and European center for Neurooncology (EZN), University Hospital Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Neuro-Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Abramson JS; Department of Medicine, Hematology, and Oncology Division, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Soumerai JD; Department of Medicine, Hematology, and Oncology Division, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Martinez-Lage M; Department of Pathology, Division of Neuropathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Haydu JE; Department of Medicine, Hematology, and Oncology Division, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Shankar GM; Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Patel C; Department of Radiation Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Choi BD; Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Barnes JA; Department of Medicine, Hematology, and Oncology Division, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; El-Jawahri A; Department of Medicine, Hematology, and Oncology Division, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Hochberg EP; Department of Medicine, Hematology, and Oncology Division, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Johnson PC; Department of Medicine, Hematology, and Oncology Division, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Wick W; Department of Neurology and European center for Neurooncology (EZN), University Hospital Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Neuro-Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Maus MV; Department of Medicine, Hematology, and Oncology Division, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Department of Medicine, Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Chen YB; Department of Medicine, Hematology, and Oncology Division, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Frigault MJ; Department of Medicine, Hematology, and Oncology Division, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Department of Medicine, Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Dietrich J; Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. jdietrich1@mgb.org.; Department of Neurology, Division of Neuro-Oncology, Neurotoxicity Clinic, Massachusetts General Hospital Cancer Center, Harvard Medical School, 55 Fruit Street, Yawkey 9E, Boston, MA, 02114, USA. jdietrich1@mgb.org.

Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722 (Electronic) Linking ISSN: 17568722 NLM ISO Abbreviation: J Hematol Oncol Subsets: MEDLINE

Toulmin SA; Harvard Combined Dermatology Residency Training Program, Boston, MA, USA.; Nazir HI; Massachusetts General Hospital Internal Medicine Residency Training Program, Boston, MA, USA.; Medical College of Georgia at Augusta University Dermatology Residency Training Program, Augusta, GA, USA.; Abramson JS; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Soumerai JD; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Freeman EE; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE; In Process

Treon SP; Dana-Farber Cancer Institute, Boston, MA, United States.; Kotton CN; Massachusetts General Hospital, Boston, MA, United States.; Park DJ; Providence St. Jude Medical Center/Providence Medical Foundation, Fullerton, CA, United States.; Moranzoni G; Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark.; Lemvigh CK; Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark.; Gathe JC Jr; Therapeutic Concepts, PA, Houston, TX, United States.; Varughese TA; Rutgers New Jersey Medical School, Newark, NJ, United States.; Barnett CF; MedStar Washington Hospital Center, Washington, DC, United States.; Belenchia JM; Archbold Medical Center, Thomasville, GA, United States.; Clark NM; Loyola University Stritch School of Medicine, Chicago, IL, United States.; Farber CM; Atlantic Health System, Morristown, NJ, United States.; Abid MB; Medical College of Wisconsin, Milwaukee, WI, United States.; Ahmed G; Medical College of Wisconsin, Milwaukee, WI, United States.; Patterson CJ; Dana-Farber Cancer Institute, Boston, MA, United States.; Guerrera ML; Dana-Farber Cancer Institute, Boston, MA, United States.; Soumerai JD; Massachusetts General Hospital, Boston, MA, United States.; Chea VA; Dana-Farber Cancer Institute, Boston, MA, United States.; Carulli IP; Dana-Farber Cancer Institute, Boston, MA, United States.; Southard J; Dana-Farber Cancer Institute, Boston, MA, United States.; Li S; Dana-Farber Cancer Institute, Boston, MA, United States.; Wu CJ; Dana-Farber Cancer Institute, Boston, MA, United States.; Livak KJ; Dana-Farber Cancer Institute, Boston, MA, United States.; Holmgren E; BeiGene USA, Inc., San Mateo, CA, United States.; Kim P; BeiGene USA, Inc., San Mateo, CA, United States.; Shi C; BeiGene USA, Inc., San Mateo, CA, United States.; Lin H; BeiGene USA, Inc., San Mateo, CA, United States.; Ramakrishnan V; BeiGene USA, Inc., San Mateo, CA, United States.; Ou Y; BeiGene USA, Inc., San Mateo, CA, United States.; Olszewski S; BeiGene USA, Inc., San Mateo, CA, United States.; Olsen LR; Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark.; Keskin DB; Dana-Farber Cancer Institute, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States.; Hunter ZR; Dana-Farber Cancer Institute, Boston, MA, United States.; Tankersley C; BeiGene USA, Inc., San Mateo, CA, United States.; Zimmerman T; BeiGene USA, Inc., San Mateo, CA, United States.; Dhakal B; Medical College of Wisconsin, Wauwatosa, WI, United States.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Kaulen LD; Division of Neuro-Oncology, Department of Neurology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Department of Neurology, University Hospital Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Neuro-Oncology, German Cancer Research Center and German Consortium for Translational Cancer Research, Heidelberg, Germany.; Martinez-Lage M; Division of Neuropathology, Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.; Abramson JS; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Karschnia P; Division of Neuro-Oncology, Department of Neurology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Department of Neurosurgery, University Hospital of Friedrich-Alexander-University, Erlangen, Germany.; Doubrovinskaia S; Department of Neurology, University Hospital Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Neuro-Oncology, German Cancer Research Center and German Consortium for Translational Cancer Research, Heidelberg, Germany.; Shankar GM; Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA.; Choi BD; Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA.; Ramundo CM; Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA.; Ehret F; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.; Department of Radiation Oncology, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium, Partner Site Berlin, a partnership between German Cancer Research Center and Charité Universitätsmedizin Berlin, Berlin, Germany.; Barnes JA; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; El-Jawahri A; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Hochberg EP; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Johnson PC; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Soumerai JD; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Plotkin SR; Division of Neuro-Oncology, Department of Neurology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Batchelor TT; Division of Neuro-Oncology, Department of Neurology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.; Wick W; Department of Neurology, University Hospital Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Neuro-Oncology, German Cancer Research Center and German Consortium for Translational Cancer Research, Heidelberg, Germany.; Maus MV; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Cellular Immunotherapy Program, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Chen YB; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Frigault MJ; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Cellular Immunotherapy Program, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Dietrich J; Division of Neuro-Oncology, Department of Neurology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Soumerai JD; Department of Medicine, Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA. Electronic address: jsoumerai@mgh.harvard.edu.; Davids MS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

Publisher: Elsevier Health Science Country of Publication: United States NLM ID: 8709473 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-1977 (Electronic) Linking ISSN: 08898588 NLM ISO Abbreviation: Hematol Oncol Clin North Am Subsets: MEDLINE

Kaulen LD; Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.; Department of Neurology, University Hospital Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Neuro-Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Karschnia P; Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.; Department of Neurosurgery, Ludwig Maximilians University (LMU), Munich, Germany.; Department of Neurosurgery, Friedrich-Alexander-University Erlangen/Nuernberg, Erlangen, Germany.; Doubrovinskaia S; Department of Neurology, University Hospital Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Neuro-Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Abramson JS; Department of Medicine, Hematology, and Oncology Division, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.; Martinez-Lage M; Department of Pathology, Division of Neuropathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Shankar G; Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Choi BD; Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Barnes JA; Department of Medicine, Hematology, and Oncology Division, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.; El-Jawahri A; Department of Medicine, Hematology, and Oncology Division, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.; Hochberg EP; Department of Medicine, Hematology, and Oncology Division, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.; Johnson PC; Department of Medicine, Hematology, and Oncology Division, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.; Soumerai JD; Department of Medicine, Hematology, and Oncology Division, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.; Wick W; Department of Neurology, University Hospital Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Neuro-Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Maus MV; Department of Medicine, Hematology, and Oncology Division, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.; Department of Medicine, Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.; Chen YB; Department of Medicine, Hematology, and Oncology Division, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.; Frigault MJ; Department of Medicine, Hematology, and Oncology Division, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.; Department of Medicine, Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.; Dietrich J; Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.

Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

Haydu JE; Lymphoma Program, Mass General Cancer Center, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Lei MM; Lymphoma Program, Mass General Cancer Center, Boston, MA.; Redd RA; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA.; Barnes JA; Lymphoma Program, Mass General Cancer Center, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Darnell EP; Lymphoma Program, Mass General Cancer Center, Boston, MA.; Hochberg EP; Lymphoma Program, Mass General Cancer Center, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Johnson PC; Lymphoma Program, Mass General Cancer Center, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Takvorian RW; Lymphoma Program, Mass General Cancer Center, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Weitzman JI; Lymphoma Program, Mass General Cancer Center, Boston, MA.; Woods EC; Lymphoma Program, Mass General Cancer Center, Boston, MA.; Hurvitz TL; Lymphoma Program, Mass General Cancer Center, Boston, MA.; Lafranchi CD; Lymphoma Program, Mass General Cancer Center, Boston, MA.; Livingstone P; Lymphoma Program, Mass General Cancer Center, Boston, MA.; Lynch JM; Lymphoma Program, Mass General Cancer Center, Boston, MA.; Patterson EN; Lymphoma Program, Mass General Cancer Center, Boston, MA.; Malespini JE; Lymphoma Program, Mass General Cancer Center, Boston, MA.; McGree BM; Lymphoma Program, Mass General Cancer Center, Boston, MA.; Santilli AO; Lymphoma Program, Mass General Cancer Center, Boston, MA.; Thorp KA; Lymphoma Program, Mass General Cancer Center, Boston, MA.; Sherburne MM; Lymphoma Program, Mass General Cancer Center, Boston, MA.; Wardrop LB; Lymphoma Program, Mass General Cancer Center, Boston, MA.; Lou UY; Lymphoma Program, Mass General Cancer Center, Boston, MA.; Sorial MN; Department of Pharmacy, Dana-Farber Cancer Institute, Boston, MA.; Cho C; Lymphoma Program, Mass General Cancer Center, Boston, MA.; Ford J; Lymphoma Program, Mass General Cancer Center, Boston, MA.; Nemac R; Lymphoma Program, Mass General Cancer Center, Boston, MA.; Soumerai JD; Lymphoma Program, Mass General Cancer Center, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Abramson JS; Lymphoma Program, Mass General Cancer Center, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.

Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 9918841988906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2950-3280 (Electronic) Linking ISSN: 29503280 NLM ISO Abbreviation: Blood Neoplasia Subsets: PubMed not MEDLINE

Nemec R; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Scherrer-Crosbie M; Division of Cardiology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.; Abramson JS; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Redd R; Department of Data Science, Dana Farber Cancer Institute, Boston, MA, USA.; Gilman HK; Division of Cardiology, Massachusetts General Hospital, Boston, MA, USA.; Ho T; Division of Cardiology, Massachusetts General Hospital, Boston, MA, USA.; Wu J; Division of Cardiology, Massachusetts General Hospital, Boston, MA, USA.; Heemelaar J; Division of Cardiology, Massachusetts General Hospital, Boston, MA, USA.; Neuberg D; Department of Data Science, Dana Farber Cancer Institute, Boston, MA, USA.; Hochberg EP; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Barnes JA; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Armand P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Jacobsen ED; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Jacobson CA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Kim AI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Friedman RS; Division of Medical Oncology, Newton-Wellesley Hospital, Newton, MA, USA.; LaCasce AS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Neilan TG; Division of Cardiology, Massachusetts General Hospital, Boston, MA, USA.; Soumerai JD; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

Lei MM; Department of Pharmacy, Massachusetts General Hospital, Boston, MA, USA.; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Sorial MN; Department of Pharmacy, Massachusetts General Hospital, Boston, MA, USA.; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Lou U; Department of Pharmacy, Massachusetts General Hospital, Boston, MA, USA.; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Yu M; School of Pharmacy, Northeastern University, Boston, MA, USA.; Medrano A; School of Pharmacy, Northeastern University, Boston, MA, USA.; Ford J; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Nemec RA; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Abramson JS; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Soumerai JD; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

Soumerai JD; Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA.; Diefenbach CS; Perlmutter Cancer Center at NYU Langone Health, New York, New York, USA.; Jagadeesh D; Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, Ohio, USA.; Asch A; Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.; Kumar A; University of Arizona, Tucson, Arizona, USA.; Tsai ML; Swedish Cancer Institute, Seattle, Washington, USA.; Jandl TA; Stony Brook University Hospital, Stony Brook, New York, USA.; Lossos IS; Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, Miami, Florida, USA.; Kenkre VP; Carbone Cancer Center, University of Wisconsin, Madison, Wisconsin, USA.; Awan F; University of Texas Southwestern Medical Center, Dallas, Texas, USA.; Novotny W; BeiGene, LTD, Cambridge, Massachusetts, USA.; Huang J; BeiGene, LTD, Cambridge, Massachusetts, USA.; Miao L; MEI Pharma, Inc., San Diego, California, USA.; Rajagopalan P; PR Consulting, Mountain Lakes, New Jersey, USA.; Ghalie RG; MEI Pharma, Inc., San Diego, California, USA.; Zelenetz AD; Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

Ababneh HS; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Ng AK; Department of Radiation Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Abramson JS; Division of Hematology and Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Soumerai JD; Division of Hematology and Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Takvorian RW; Division of Hematology and Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Frigault MJ; Division of Hematology and Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Patel CG; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8307268 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1099-1069 (Electronic) Linking ISSN: 02780232 NLM ISO Abbreviation: Hematol Oncol Subsets: MEDLINE

Yoon JT; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Zhou Y; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.; Mikhaleva M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Choi DS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Fernandes SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Armand P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Bessnow AC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Crombie JL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Fisher DC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Jacobsen ED; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Jacobson CA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Kim AI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; LaCasce AS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Merryman RW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Odejide OO; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Parry EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Qualls DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Ryan CE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Sekar A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Soumerai JD; Harvard Medical School, Boston, MA.; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA.; Arnason J; Harvard Medical School, Boston, MA.; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA.; Tyekucheva S; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.; Davids MS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Brown JR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Ahn IE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.

Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE